switching between glp-1 agonists Frontiers Emerging Trends in the Development

Health effects of overweight and obesity in 195 countries over 25 years

As research continues, these medications may become an important tool for managing a wide range of conditions, from metabolic and cardiovascular health to neuroinflammation and mast cell disorders

(2008) 295:E77984

They highlighted the need to consider potential tradeoffs between efficacy and side effects, finding that higher doses can have stronger efficacy but also induce more severe side effects

In high-stress states, the body prioritizes survival over satiety, which can blunt GLP-1s effects

The SURMOUNT clinical program demonstrated substantial weight reductions establishing tirzepatide as one of the most effective obesity medications available